Phosphate Sandoz™ is an effervescent tablet containing 1.936g of anhydrous sodium acid phosphate, and is indicated for hypercalcaemia associated with such conditions as hyperparathyroidism, multiple myelomatosis and malignancy, hypophosphataemia associated with vitamin D resistant rickets and vitamin D resistant hypophosphataemic osteomalacia. Adult dosing is up to 6 tablets daily for hypercalcaemia, and 4-6 tablets for hypophosphataemic osteomalacia. Children (under 5) are dosed at half this rate. Phosphate Sandoz™ is sold in five tubes of twenty tablets.